Applications of tissue engineering in the genitourinary tract

Expert Review of Medical Devices

Volumn 2, Issue 1, 2005, Pages 119-126

  Atala, Anthony ^a   Koh, Chester ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Bladder; Genitourinary tract; Kidney; Regenerative medicine; Tissue engineering; Urethra; Urinary tract

Indexed keywords

ALGINIC ACID; ANDROGEN; ANDROSTANOLONE; BIOMATERIAL; BIOPOLYMER; COLLAGEN; ESTRADIOL; MITOCHONDRIAL DNA; POLYESTER; POLYGLACTIN; POLYGLYCOLIC ACID; POLYLACTIC ACID; TESTOSTERONE;

BIOCOMPATIBILITY; BLADDER DISEASE; BONE DENSITY; BONE DISEASE; CARTILAGE CELL; CELL ENCAPSULATION; CELL TRANSPLANTATION; CLINICAL TRIAL; CONGENITAL DISORDER; DRUG DELIVERY SYSTEM; ERYTHROPOIESIS; EXTRACELLULAR MATRIX; FLUID RETENTION; GENETIC DISORDER; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; HYPOGONADISM; KIDNEY DISEASE; MUSCLE CELL; MYOBLAST; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SIDE EFFECT; STEM CELL; T LYMPHOCYTE; TESTIS DISEASE; TISSUE ENGINEERING; TISSUE REGENERATION; URETHRA DISEASE; URINE INCONTINENCE; UROGENITAL TRACT DISEASE; VESICOURETERAL REFLUX;

EID: 12344331523     PISSN: 17434440     EISSN: None     Source Type: Journal    
DOI: 10.1586/17434440.2.1.119     Document Type: Review

References (95)

1. Chen F, Yoo JJ, Atala A. Acellular collagen matrix as a possible off the shelf biomaterial for urethral repair. Urology 54, 407-410 (1999).
2. Dahms SE, Piechota HJ, Dahiya R et al. Composition and biomechanical properties of the bladder acellular matrix graft: comparative analysis in rat, pig and human. Br. J. Urol. 82, 411-419 (1998).
3. Piechota HJ, Dahms SE, Nunes LS et al. In vitro functional properties of the rat bladder regenerated by the bladder acellular matrix graft. J. Urol. 159, 1717-1724 (1998).
4. Yoo JJ, Meng J, Oberpenning F et al. Bladder augmentation using allogenic bladder submucosa seeded with cells. Urology 51, 221-225 (1998).
5. Amiel GE, Atala A. Current and future modalities for functional renal replacement. Urol. Clin. North Am. 26, 235-246 (1999).
6. Borer JG, Cisek LJ, Atala A et al. Pediatric retroperitoneoscopic nephrectomy using 2 mm instrumentation. J. Urol. 162, 1725-1729 (1999).
7. Atala A, Freeman MR, Vacanti JP et al. Implantation in vivo and retrieval of artificial structures consisting of rabbit and human urothelium and human bladder muscle. J. Urol. 150, 608-612 (1993).
8. Atala A, Guzman L, Retik AB. A novel inert collagen matrix for hypospadias repair. J. Urol. 162, 1148-1151 (1999).
9. Atala A, Kim W, Paige KT et al. Endoscopic treatment of vesicoureteral reflux with a chondrocyte-alginate suspension. J. Urol. 152, 641-643 (1994).
10. Atala A, Lanza RP. Preface. In: Methods of Tissue Engineering. Academic Press, CA, USA (2001).
11. Atala A, Mooney D. Preface. In: Tissue Engineering. Atala A (Ed.). Birkhauser Press, MA, USA (1997).
12. Cilento BG, Freeman MR, Schneck FX et al. Phenotypic and cytogenetic characterization of human bladder urothelia expanded in vitro. J. Urol. 152, 665-670 (1994).
13. Fauza DO, Fishman SJ, Mehegan K et al. Videofetoscopically assisted fetal tissue engineering: bladder augmentation. J. Pediatr. Surg. 33, 7-12 (1998).
14. Fauza DO, Fishman SJ, Mehegan K et al. Videofetoscopically assisted fetal tissue engineering: skin replacement. J. Pediatr. Surg. 33, 357-361 (1998).
15. Godbey WT, Atala A. In vitro systems for tissue engineering. Ann. NY Acad. Sci. 961, 10-26 (2002).
16. Kershen RT, Atala A. New advances in injectable therapies for the treatment of incontinence and vesicoureteral reflux. Urol. Clin. North Am. 26, 81-94 (1999).
17. Machluf M, Atala A. Emerging concepts for tissue and organ transplantation. Graft 1, 31 (1998).
18. Oberpenning F, Meng J, Yoo JJ et al. De novo reconstitution of a functional mammalian urinary bladder by tissue engineering. Nature Biotechnol. 17, 149-155 (1999).
19. Park HJ, Yoo JJ, Kershen RT et al. Reconstitution of human corporal smooth muscle and endothelial cells in vivo. J. Urol. 162, 1106-1109 (1999).
20. Yoo JJ, Atala A. A novel gene delivery system using urothelial tissue engineered neo-organs. J. Urol. 158, 1066-1070 (1997).
21. Yoo JJ, Lee I, Atala A. Cartilage rods as a potential material for penile reconstruction. J. Urol. 160, 1164-1168 (1998 ).
22. Scriven SD, Booth C, Thomas DF et al. Reconstitution of human urothelium from monolayer cultures. J. Urol. 158, 1147-1152 (1997).
23. Liebert M, Hubbel A. Chung M et al. Expression of mal is associated with urothelial differentiation in vitro: identification by differential display reverse-transcriptase polymerase chain reaction. Differentiation 61, 177-1185 (1997).
24. Puthenveettil JA, Burger MS, Reznikoff CA. Replicative senescence in human uroepithelial cells. Adv. Exp. Med. Biol. 462, 83-91 (1999).
25. Freeman MR, Yoo JJ, Raab G et al. Heparin-binding EGF-like growth factor is an autocrine growth factor for human urothelial cells and is synthesized by epithelial and smooth muscle cells in the human bladder. J. Clin. Invest. 99, 1028-1036 (1997).
26. Nguyen HT, Park JM, Peters CA et al. Cell-specific activation of the HB-EGF and ErbB1 genes by stretch in primary human bladder cells. In Vitro Cell. Dev. Biol. Anim. 35, 371-375 (1999).
27. Liebert M, Wedemeyer G, Abruzzo LV et al. Stimulated urothelial cells produce cytokines and express an activated cell surface antigenic phenotype. Semin. Urol. 9, 124-130 (1991).
28. Tobin MS, Freeman MR, Atala A. Maturational response of normal human urothelial cells in culture is dependent on extracellular matrix and serum additives. Surg. Forum 45, 786 (1994).
29. Harriss DR. Smooth muscle cell culture: a new approach to the study of human detrusor physiology and pathophysiology. Br. J. Urol. 75, 18-26 (1995).
30. Solomon LZ, Jennings AM, Sharpe P et al. Effects of short-chain fatty acids on primary urothelial cells in culture: implications for intravesical use in enterocystoplasties. J. Lab. Clin. Med. 132, 279-283 (1998).
31. Lobban ED, Smith BA, Hall GD et al. Uroplakin gene expression by normal and neoplastic human urothelium. Am. J. Pathol. 153, 1957-1967 (1998).
32. Rackley RR, Bandyopadhyay SK, Fazeli-Matin S et al. Immunoregulatory potential of urothelium: characterization of NF-κB signal transduction. J. Urol. 162, 1812-1816 (1999).
33. Kim BS, Mooney DJ. Development of biocompatible synthetic extracellular matrices for tissue engineering. Trends Biotechnol. 16, 224-230 (1998).
34. Bergsma JE, Rozema FR, Bos RR et al. In vivo degradation and biocompatibility study of in vitro predegraded aspolymerized polyactide particles. Biomaterials 16, 267-274 (1995).
35. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 69, 11-25 (1992).
36. Deuel TF. Growth Factors. In: Principles of Tissue Engineering. Lanza RP, Langer R, Chick WL (Eds). Academic Press, NY, USA, 133-149 (1997).
37. Pariente JL, Kim BS, Atala A. In vitro biocompatibility assessment of naturally derived and synthetic biomaterials using normal human urothelial cells. J. Biomed. Mater. Res. 55, 33-39 (2001).
38. Pariente JL, Kim BS, Atala A. In vitro biocompatibility evaluation of naturally derived and synthetic biomaterials using normal human bladder smooth muscle cells. J. Urol. 167, 1867-1871 (2002).
39. Li ST. Biologic biomaterials: tissue-derived biomaterials (collagen). In: The Biomedical Engineering Handbook. Brozino JD (Ed.). CRS Press, FL, USA, 627-647 (1995).
40. Silver FH, Pins G. Cell growth on collagen: a review of tissue engineering using scaffolds containing extracellular matrix. J. Long-Term Effects Med. Implants 2, 67-80 (1992).
41. Sams AE, Nixon AJ. Chondrocyte-laden collagen scaffolds for resurfacing extensive articular cartilage defects. Osteoarthritis Cartilage 3, 47-59 (1995).
42. Smidsrod O, Skjak-Braek G. Alginate as immobilization matrix for cells. Trends Biotechnol. 8, 71-78 (1990).
43. Lim F, Sun AM. Microencapsulated islets as bioartificial endocrine pancreas. Science 210, 908-910(1980).
44. Gilding DK. Biodegradable polymers. In: Biocompatibility of Clinical Implant Materials. Williams DF (Ed.). CRC Press, FL, USA, 209-232 (1981).
45. Freed LE, Vunjak-Novakovic G, Biron RJ et al. Biodegradable polymer scaffolds for tissue engineering. Biotechnology 12, 689-693 (1994).
46. Mikos AG, Thorsen AJ, Czerwonka LA et al. Preparation and characterization of poly(L-lactic acid) foams. Polymer 35, 1068 (1994).
47. Harris LD, Kim BS, Mooney DJ. Open pore biodegradable matrices formed with gas foaming. J. Biomed. Mater. Res. 42, 396-402 (1998).
48. Peppas NA, Langer R. New challenges in biomaterials. Science 263, 1715-1720 (1994).
49. Bazeed MA, Thuroff JW, Schmidt RA et al. New treatment for urethral strictures. Urology 21, 53-57 (1983).
50. Atala A, Vacanti JP, Peters CA et al. Formation of urothelial structures in vivo from dissociated cells attached to biodegradable polymer scaffolds in vitro. J. Urol. 148, 658-662 (1992).
51. Olsen L, Bowald S, Busch C et al. Urethral reconstruction with a new synthetic absorbable device. An experimental study. Scand. J. Urol. Nephrol. 26, 323-326 (1992).
52. Kropp BP, Ludlow JK, Spicer D et al. Rabbit urethral regeneration using small intestinal submucosa onlay grafts. Urology 52, 138-142 (1998).
53. Sievert KD, Bakircioglu ME, Nunes L et al. Homologous acellular matrix graft for urethral reconstruction in the rabbit: histological and functional evaluation. J. Urol. 163, 1958-1965 (2000).
54. El-Kassaby AW, Retik AB, Yoo JJ et al. Urethral stricture repair with an off-the-shelf collagen matrix. J. Urol. 169, 170-173 (2003).
55. De Filippo RE, Pohl HG, Yoo JJ et al. Total penile urethral replacement with autologous cell-seeded collagen matrices. J. Urol. 167(SuppL), 152 (2002).
56. De Filippo RE, Yoo JJ, Atala A. Urethral replacement using cell seeded tubularized collagen matrices. J. Urol. 168, 1789-1792 (2002).
57. Atala A. Freeman MR, Vacanti JP et al. Implantation in vivo and retrieval of artificial structures consisting of rabbit and human urothelium and human bladder muscle. J. Urol. 150, 608-612 (1993).
58. Oberpenning F, Meng J, Yoo JJ et al. De novo reconstitution of a functional mammalian urinary bladder by tissue engineering. Nature Biotechnol. 17, 149-155 (1999).
59. Lanza RP, Chung HY, Yoo JJ et al. Generation of histocompatible tissues using nuclear transplantation. Nature Biotechnol. 20, 689-696 (2002).
60. Auchincloss H, Bonventre JV. Transplanting cloned cells into therapeutic promise. Nature Biotechnol. 20, 665-666 (2002).
61. Aebischer P, Ip TK, Panol G, Galletti PM. The bioartificial kidney: progress towards an ultrafiltration device with renal epithelial cells processing. Life Support Systems 5, 159-168 (1987).
62. Amiel GE, Yoo JJ, Atala A. Renal therapy using tissue-engineered constructs and gene delivery. World J. Urol. 18, 71-79 (2000).
63. Humes HD, Buffington DA, MacKay SM et al. Replacement of renal function in uremic animals with a tissue-engineered kidney. Nature Biotechnol. 17, 451-455 (1999).
64. Ip TK, Aebischer P, Galletti PM. Cellular control of membrane permeability. Implications for a bioartificial renal tubule. ASAIO Trans. 34, 351-355 (1988).
65. Joki T, Machluf M, Atala A et al. Continuous release of endostatin from microencapsulated engineered cells for tumor therapy. Nature Biotechnol. 19, 35-39 (2001).
66. Lanza RP, Hayes JL, Chick WL. Encapsulated cell technology. Nature Biotechnol. 14, 1107-1111 (1996).
67. MacKay SM, Funke AJ, Buffington DA et al. Tissue engineering of a bioartificial renal tubule. ASAIO J. 44, 179-183 (1998).
68. Evans MJ, Gurer C, Loike JD et al. Mitochondrial DNA genotypes in nuclear transfer-derived cloned sheep. Nature Genet. 23, 90-93 (1999).
69. Hiendleder S, Schmutz SM, Erhardt G et al. Transmitochondrial differences and varying levels of heteroplasmy in nuclear transfer cloned cattle. Mol. Reprod. Dev. 54, 24-31 (1999 ).
70. Steinborn R, Schinogl P, Zakhartchenko V et al. Mitochondrial DNA heteroplasmy in cloned cattle produced by fecal and adult cell cloning. Nature Genet. 25, 255-257 (2000).
71. Fischer Lindahl K, Hermel E, Loveland BE et al. Maternally transtrutted antigen of mice: a model transplantation antigen. Ann. Rev. Immunol. 9, 351-372 (1991).
72. Hadley GA, Linders B, Mohanakumar T. Imminogenicity of MHC class I alloantigens expressed on parenchymal cells in the human kidney. Transplantation 54, 537-542 (1992).
73. Yard BA, Kooymans-Couthino M, Reterink T et al. Analysis of T-cell lines from rejecting renal allogafts. Kidney Internatl 39(Suppl.), S133-S138 (1993).
74. Lanza RP, Chung HY, Yoo JJ et al. Generation of histocompatible tissues using nuclear transplantation. Nature Biotechnol. 20, 689-696 (2002).
75. Dekel B, Amariglio N, Kaminski N et al. Engraftment and differentiation of human metanephroi into functional mature nephrons after transplantation into mice is accompanied by a profile of gene expression similar to normal human kidney development. J. Am. Soc. Nephrol. 13, 977-990 (2002).
76. Dekel B, Burakova T, Arditti FD et al. Human and porcine early kidney precursors as a new source for transplantation. Nature Med. 9, 53-60 (2003).
77. Holroyd-Leduc JM, Straus SE. Management of urinary incontinence in women: scientific review. JAMA 291, 986-995 (2004 ).
78. Brown JS, Nyberg LM, Kusek JW et al. Proceedings of the National Institute of Diabetes and Digestive and Kidney Diseases International Symposium on Epidemiologic Issues in Urinary Incontinence in Women. Am. J. Obstet. Gynecol. 188, S77-S88 (2003).
79. Burgio KL, Matthews KA, Engel BT. Prevalence, incidence and correlates of urinary incontinence in healthy, middle-aged women. J. Urol. 146, 1255-1259(1991).
80. Wilson L, Brown JS, Shin GP et al. Annual direct cost of urinary incontinence. Obstet. Gynecol. 98, 398-406 (2001).
81. Atala A, Cima LG, Kim W et al. Injectable alginate seeded with chondrocytes as a potential treatment for vesicoureteral reflux. J. Urol. 150, 745-747 (1993).
82. Retik AB, Mandell J, Bauer SB et al. Metal based hypospadias repair with the use of a dorsal subcutaneous flap to prevent urethrocutaneous fistula. J. Urol. 152, 1229-1231 (1994).
83. Diamond DA, Caldamone AA. Endoscopic correction of vesicoureteral reflux in children using autologous chondrocytes: preliminary results. J. Urol. 162, 1185-1188 (1999).
84. Bent A, Tutrone R, McLennan M et al. Treatment of intrinsic sphincter deficiency using autologous ear chondrocytes as a bulking agent. Neurourol. Urodynam. 20, 157-165 (2001).
85. Yokoyama T, Chancellor MB, Watanabe T et al. Primary myoblasts injection into the urethra and bladder as a potential treatment of stress urinary incontinence and impaired detrusor contractility: long-term survival without significant cytotoxicity. J. Urol. 161, 307 (1999).
86. Chancellor MB, Yokoyama T, Tirney S et al. Preliminary results of myoblast injection into the urethra and bladder wall: a possible method for the treatment of stress urinary incontinence and impaired detrusor contractility. Neurourol. Urodynam. 19, 279-287 (2000).
87. Strasser H, Marksteiner R, Eva M et al. Transurethral ultrasound guided injection of clonally cultured autologous myoblasts and fibroblasts: experimental results. Presented at the Proceedings of the 2003 International Bladder Symposium, Arlington, VA (2003).
88. Yiou R, Lefaucheur JP, Atala A. The regeneration process of the striated urethral sphincter involves activation of intrinsic satellite cells. Anat. Embryol. 206, 429-435 (2003).
89. Yiou R, Yoo JJ, Atala A. Restoration of functional motor units in a rat model of sphincter injury by muscle precursor cell autografts. Transplantation 76, 1053-1060 (2003).
90. Machluf M, Orsola A, Boorjian S et al. Microencapsulation of Leydig cells: a system for testosterone supplementation. Endrocrinology 144, 4975-4979 (2003).
91. Santen RJ, Swerdloff RS. Clinical aspects of androgen therapy. Presented at the Workshop Conference on Androgen Therapy: Biologic and Clinical Consequences. Penn State Workshop Proceedings PA, USA (1990).
92. Tai J, Johnson HW, Tze WJ. Successful transplantation of Leydig cells in castrated inbred rats. Transplantation 47, 1087-1089 (1989).
93. van Dam JH, Teerds KJ, Rommerts FF. Transplantation and subsequent recovery of small amounts of isolated Leydig cells. Arch. Androl. 22, 123-129 (1989).
94. De Vos P, De Haan B, Van Schilfgaarde R. Effect of the alginate composition on the biocompatibility of alginate-polylysine microcapsules. Biamaterials 18, 273-278 (1997).
95. Tai IT, Sun AM. Microencapsulation of recombinant cells: a new delivery system for gene therapy. FASEB J. 7, 1061-1069 (1993).